All the Data, Tools, and Care in One Psychedelic Platform

Clinical Trial Tracker on Neuly Neuly Insights - Analysis on the Psychedelics Industry Neuly's list of investors in the psychedelics industry Neuly's list of research in the psychedelics industry

Your One-Stop Connection to Psychedelics

  • Our technology collects and analyzes data so that you don't have to
  • Our team researches industry updates to keep you in the know
  • Leverage tools that can be customized for your business
  • Find and book clinics, therapists, coaches, and retreats
  • Connect with industry professionals to help grow the industry

Signup Request Data

Or learn more about Neuly

Who is Neuly For?

Entrepreneurs, investors, researchers, scientists, educators, policy makers, and anyone interested in the psychedelics industry.

Join today to get access to our extensive psychedelic database + your Neuly dashboard to follow & save info, take notes, and more.


Recent Job Postings

Instruction Associate- Psychedelic Therapies and Research

Mar 13, 2023

San Francisco, California, USA

Full Time

Center Manager - Psychedelic Therapies and Research

Mar 08, 2023

San Francisco, California, USA

Full Time

Psychedelic-Assisted Therapies Cohort Integration Leader

Mar 01, 2023

Boulder, Colorado, USA

Full Time

Upcoming Events

Psychedelic Science 2023

Jun 17, 2023

Denver, Colorado, USA

Psychedelic Science 2023

Jun 18, 2023

Denver, Colorado, USA

Education, Marketplace, Community

Recruiting Clinical Trials in Psychedelics

Interested in participating in a clinical trial as a patient or healthy volunteer? Browse, filter, and search through 184 clinical trials that are actively recruiting to find a match for you.

View Recruiting Clinical Trials

Top 3 Trending News

Scientists Reveal How DMT Affects the Brain's Advanced Functions | Psychedelic Spotlight

Mar 21, 2023 – In comparison to other psychedelics like LSD and psilocybin, DMT is observed to take users into an altogether more intricate and immersive state ...


MDMA, psilocybin treatments tipped to cost at least $25,000 - Sydney Morning Herald

Mar 21, 2023 – Australians are expected to pay out-of-pocket costs of at least $25,000 to receive MDMA and psilocybin therapy when the psychedelic drugs become ...


AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 2.5% - Defense World

Mar 21, 2023 – AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Rating) shares dropped 2.5% on Monday . The stock traded as low as $1.70 and last traded at ...


Non-Profits by Focus

View Non-Profits by Focus

Explore Non-Profits

Organizations by Type

Explore Organizations

Neuly Insights

Register for your free account to get access to all Neuly Insights.

Join Neuly

Investment Funds & Organizations

View Neuly's Investment Funds Chart

View Investment Funds

Organizations By Drug Focus

Explore by Focus

Top 10 Locations for People

Explore Locations

How Neuly Can Help You

We've made complicated data and information easy to understand.


Find high-quality, low-cost solutions for your start up.


Share your findings with a dedicated network of experts.


Stay up to date about company progress with alerts.


Provide your students with the most relevant information.


Stop hunting for information across multiple platforms.


Access a deep database of resources.

Policy Makers

Understand industry data to help you make informed decisions.